Key Predictive Biomarkers Market Players:
- Siemens Healthcare GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- F. Hoffmann-La Roche Ltd
- Epigenomics AG
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN GmbH
- Danaher Corporation
- Biomarker Technologies, Inc.
- Almac Group Limited
- Myriad Genetics, Inc.
- Meso Scale Diagnostics, LLC
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of predictive biomarkers is evaluated at USD 32.3 billion.
The global predictive biomarkers market size exceeded USD 27.69 billion in 2025 and is set to expand at a CAGR of over 18.5%, surpassing USD 151.18 billion revenue by 2035.
North America in the predictive biomarkers market is projected to command a 35% revenue share by 2035 supported by advanced research and development activities in the healthcare sector.
Key players in the market include Eaton Corporation Plc, Hitachi ABB Power Grids, CG Power and Industrial Solutions Ltd., DAIHEN Corp., Schneider Electric SE, Siemens AG, STC Inc., Bharat Heavy Electricals Ltd., ENERCON GmbH, General Electric Company.
